Correct Capital Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Hold
1,754
– – 0.36% 38
2026
Q1
$1.61M Sell
1,754
-149
-8% -$151K 0.3% 44
2025
Q4
$2.05M Buy
1,903
+48
+3% +$45.9K 0.38% 39
2025
Q3
$1.42M Buy
1,855
+367
+25% +$273K 0.23% 53
2025
Q2
$1.16M Buy
1,488
+1,009
+211% +$784K 0.17% 54
2025
Q1
$395K Buy
479
+30
+7% +$25K 0.06% 90
2024
Q4
$346K Buy
449
+29
+7% +$24K 0.07% 90
2024
Q3
$372K Sell
420
-79
-16% -$71K 0.08% 95
2024
Q2
$452K Hold
499
– – 0.11% 81
2024
Q1
$388K Hold
499
– – 0.09% 96
2023
Q4
$291K Buy
+499
New +$291K 0.07% 101

Other funds holding LLY

Correct Capital Wealth Management's LLY Position: Q2 2026 in Review

Correct Capital Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 1,754 shares worth $2.1M. The position accounts for 0.36% of the portfolio, ranked #38.

Correct Capital Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Correct Capital Wealth Management held 1,754 shares of Eli Lilly worth $2.1M as of Q2 2026.
  • Correct Capital Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.36% of Correct Capital Wealth Management's portfolio in Q2 2026, its #38 holding.
  • Correct Capital Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Correct Capital Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.